[HTML][HTML] Continuing controversy regarding individualized surgical decision-making for patients with 1–4 cm low-risk differentiated thyroid carcinoma: a systematic …

W Liu, X Yan, R Cheng - European Journal of Surgical Oncology, 2020 - Elsevier
Implementing high-quality randomized controlled trials is difficult for patients with 1–4 cm
low-risk differentiated thyroid carcinoma (DTC). Controversy exists regarding whether …

Frequency of high-risk characteristics requiring total thyroidectomy for 1–4 cm well-differentiated thyroid cancer

WP Kluijfhout, JD Pasternak, J Lim, JS Kwon… - Thyroid, 2016 - liebertpub.com
Background: The extent of thyroidectomy for low-risk well-differentiated thyroid cancer
(WDTC) remains controversial. Historically, total thyroidectomy (TT) has been recommended …

Current surgical treatment of intermediate risk differentiated thyroid cancer: a systematic review

MY Guo, JJ Wiseman, SM Wiseman - Expert Review of Anticancer …, 2021 - Taylor & Francis
Introduction: Surgical treatment of thyroid cancer has become less aggressive but for many
patients, the threshold for performing total thyroidectomy (TT), as opposed to thyroid …

Total thyroidectomy versus lobectomy for thyroid cancer: single-center data and literature review

C Colombo, S De Leo, M Di Stefano, M Trevisan… - Annals of surgical …, 2021 - Springer
Background Controversies remain about the ideal risk-based surgical approach for
differentiated thyroid cancer (DTC). Methods At a single tertiary care institution, 370 …

Thyroid lobectomy is associated with excellent clinical outcomes in properly selected differentiated thyroid cancer patients with primary tumors greater than 1 cm

F Vaisman, D Momesso, DA Bulzico… - Journal of thyroid …, 2013 - Wiley Online Library
Background and Objective. An individualized risk‐based approach to the treatment of
thyroid cancer is being extensively discussed in the recent literature. However, controversies …

The impact of the extent of surgery on the long-term outcomes of patients with low-risk differentiated non-medullary thyroid cancer: a systematic meta-analysis

A Bojoga, A Koot, J Bonenkamp, J de Wilt… - Journal of Clinical …, 2020 - mdpi.com
Recently, the management of patients with low-risk differentiated non-medullary thyroid
cancer (DTC), including papillary and follicular thyroid carcinoma subtypes, has been …

Surgical management of primary thyroid tumours

P Asimakopoulos, IJ Nixon - European Journal of Surgical Oncology, 2018 - Elsevier
The majority of patients who present with well differentiated thyroid cancer will require
surgery, but decisions on the appropriate primary procedure will depend on information …

Thyroid lobectomy for low to intermediate risk differentiated thyroid cancer

DM Hartl, J Guerlain, I Breuskin, J Hadoux, E Baudin… - Cancers, 2020 - mdpi.com
Simple Summary Total thyroidectomy used to be recommended for all thyroid cancers. We
now know that some thyroid cancers have a relatively low risk of recurrence. Today, for …

Long-term outcome of lobectomy for thyroid cancer

M Bosset, M Bonjour, S Castellnou… - European Thyroid …, 2021 - etj.bioscientifica.com
Introduction: Recent guidelines of the American Thyroid Association (ATA) suggest that a
lobectomy may be sufficient to treat low-to intermediate-risk patients with thyroid tumors≤ 40 …

[HTML][HTML] The ongoing debate regarding completion thyroidectomy versus primary thyroid surgery for low and intermediate differentiated thyroid carcinoma: a meta …

H Mirghani, IAA Albalawi - Cureus, 2020 - ncbi.nlm.nih.gov
Lobectomy is increasingly performed for low-risk differentiated thyroid cancer (DTC) and
papillary thyroid microcarcinoma (PTMC). However, there is a continuous controversy about …